Skip to main content
NCBI home page
Cell Proliferation logoLink to Cell Proliferation
. 2003 Jan 31;32(5):289–302. doi: 10.1046/j.1365-2184.1999.3250289.x

Role of proliferation and apoptosis in net growth rates of human breast cancer cells (MCF‐7) treated with oestradiol and/or tamoxifen

P E Budtz 1
PMCID: PMC6726337  PMID: 10619490

Abstract

Abstract. Studies on growth regulation in vitro to a large extent rely on comparison of growth curves. However, these do not discriminate between the relative contributions of the mitotic rate and the apoptotic rate to the net growth rate. In the present study, differential effects of 17β‐oestradiol (E2, 10−8 M) and/or tamoxifen (TAM, 10−6 M) on proliferation and apoptosis have been examined and related to growth curves of a subline of the human breast cancer cell line MCF‐7 adapted to grow at low serum concentrations. Counting of cells and scoring of labelling and apoptotic indices were performed at the start of the experiment and 3, 6 and 9 days after changing the experimental media. The results demonstrate that apoptosis in this subline is constitutively expressed, that E2 protects (at least partly) against apoptosis and stimulates proliferation, resulting in an increased (net) growth rate and final cell pool size, and that TAM has a weak cytostatic effect and stimulates apoptosis strongly, resulting in a decreased (net) growth rate and final cell pool size. When E2 and TAM are added simultaneously to the medium, the cytotoxic effect of TAM is partly counterbalanced by the protective role of E2, resulting in a reduced apoptotic rate that, however, is at a higher level than in cultures grown with E2 only. As the cytostatic role of TAM is partly abolished by E2, the combined effect of E2 and TAM results in a final (net) growth rate and cell pool size intermediary to cells grown with E2 or TAM alone.

Full Text

The Full Text of this article is available as a PDF (1.7 MB).

REFERENCES

  1. Aten JA, Bakker PJM, Stap J, Boschman GA, Veenhof CHN. (1992) DNA double‐labelling with IdUrd and CldUrd for spatial and temporal analysis of cell proliferation and DNA replication. Histochem. J. 24, 251. [DOI] [PubMed] [Google Scholar]
  2. Bardon S, Vignon F, Derocq D, Rochefort H. (1984) The antiproliferative effect of tamoxifen in breast cancer cells: mediation by the estrogen receptor. Mol. Cell. Endocrinol. 35, 89. [DOI] [PubMed] [Google Scholar]
  3. Berthois Y, Katzenellenbogen JA, Katzenellenbogen BS. (1986) Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen‐responsive cells in culture. Proc. Natl. Acad. Sci. USA 83, 2496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Briand P, Lykkesfeldt AE. (1984) Effect of estrogen and antiestrogen on the human breast cancer cell line MCF‐7 adapted to growth at low serum concentration. Cancer Res. 44, 1114. [PubMed] [Google Scholar]
  5. Bruno S, Di Vinci A, Geido E, Giaretti W. (1988) Cell cycle synchronization induced by tamoxifen and 17β‐estradiol on MCF‐7 cells using flow cytometry and a monoclonal antibody against bromodeoxyuridine. Breast Cancer Res. Treat. 11, 221. [DOI] [PubMed] [Google Scholar]
  6. Brünner N, Bronzert D, Vindeløv LL, Rygaard K, Spang‐thomsen M, Lipmann ME. (1989) Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF‐7 human breast cancer cells grown in vitro and in nude mice. Cancer Res. 49, 1515. [PubMed] [Google Scholar]
  7. Bursch W, Ellinger A, Kienzl H et al. (1996) Active cell death induced by the antiestrogens tamoxifen and ICI 164, 384 in human mammary carcinoma cells (MCF‐7) in culture: the role of autophagy. Carcinogenesis 17, 1595. [DOI] [PubMed] [Google Scholar]
  8. Cai J, Lee CW. (1996. Tamoxifen inhibits nitrobenzylthioinosine‐sensitive equilibrative uridine transport in human MCF‐7 breast cancer cells. Biochem. J. 320, 991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cavailles V, Augereau P, Garcia M, Rochefort H. (1988) Estrogens and growth factors induce mRNA of the 52K‐pro‐cathepsin‐D secreted by breast cancer cells. Nucl Acids Res. 16, 1903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chen H, Tritton TR, Kenny N, Absher M, Chiu JF. (1996) Tamoxifen induces TGF‐β1 activity of human breast cancer cells in vitro . J. Cell. Biochem. 61, 9. [DOI] [PubMed] [Google Scholar]
  11. Frankfurt OS, Sugarbaker EV, Robb JA, Villa L. (1995) Synergistic induction of apoptosis in breast cancer cells by tamoxifen and calmodulin inhibitors. Cancer Lett 97, 149. [DOI] [PubMed] [Google Scholar]
  12. Gulino A, Barrera G, Vacca A et al. (1986) Calmodulin antagonism and growth inhibiting activity of triphenylethylene anti‐estrogens in MCF‐7 human breast cancer cells. Cancer Res. 46, 6274. [PubMed] [Google Scholar]
  13. Kasid A, Davidson NE, Gelmann EP, Lippmann ME. (1986) Transcriptional control of thymidine kinase gene expression by estrogen and antiestrogens in MCF‐7 human breast cancer cells. J. Biol. Chem. 261, 5562. [PubMed] [Google Scholar]
  14. Kerr JFR, Wyllie AH, Currie AR. (1973) Apoptosis: a basic biological phenomenon with wide‐ranging implications in tissue kinetics. Br. J. Cancer 26, 239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kyprianou N, English HF, Davidson NE, Isaacs JT. (1991) Programmed cell death during regression of the MCF‐7 human breast cancer following estrogen ablation. Cancer Res. 51, 162. [PubMed] [Google Scholar]
  16. Lam H‐YP. (1984) Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase. Biochem. Biophys. Res. Commun. 118, 27. [DOI] [PubMed] [Google Scholar]
  17. Laursen I, Lykkesfeldt AE. (1992) Purification and characterization of an a1‐antichymotrypsin‐like 66 kDa protein from the human breast cancer cell line MCF‐7. Biochim. Biophys. Acta 1121, 119. [DOI] [PubMed] [Google Scholar]
  18. Laursen I, Briand P, Lykkesfeldt AE. (1990) Serum albumin as a modulator on growth of the human breast cancer cell line, MCF‐7. Anticancer Res. 10, 343. [PubMed] [Google Scholar]
  19. Leung BS, Potter AH. (1987) Mode of estrogen action on cell proliferation in CAMA‐1 cells: II. Sensitivity of G1 phase population. J. Cell. Biochem. 34, 213–225. [DOI] [PubMed] [Google Scholar]
  20. Lippman M, Bolan G, Huff K. (1976) Interactions of antiestrogens with human breast cancer in long‐term tissue culture. Cancer Treat. Report 60, 1421. [PubMed] [Google Scholar]
  21. Lykkesfeldt AE. (1997) Growth regulation of human breast cancer cells by estrogens and antiestrogens. Thesis, University of Copenhagen (ISBN 87‐90212‐142).
  22. Lykkesfeldt AE, Briand P. (1986) Indirect mechanism of oestradiol stimulation of cell proliferation of human breast cancer cell lines. Br. J. Cancer 53, 29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lykkesfeldt AE, Larsen JK, Christensen IJ, Briand P. (1984) Effects of the antiestrogen tamoxifen on the cell cycle kinetics of the human breast cancer cell line, MCF‐7. Br. J. Cancer 49, 717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Lykkesfeldt AE, Larsen JK, Christensen IJ, Briand P. (1986a) Cell cycle analysis of estrogen‐stimulated growth of the human breast cancer cell line MCF‐7. Eur. J. Cancer Clin. Oncol. 22, 439. [DOI] [PubMed] [Google Scholar]
  25. Lykkesfeldt AE, Larsen JK, Christensen IJ. (1986b) Cell cycle analysis of estrogen stimulation and antiestrogen inhibition of growth of the human breast cancer cell line MCF‐7. Breast Cancer Res. Treat. 7 (Suppl), 83. [PubMed] [Google Scholar]
  26. Lykkesfeldt AE, Laursen I, Briand P. (1989) Regulation of the secretion of proteins synthesized by the human breast cancer cell line, MCF‐7. Mol. Cell. Endocrinol. 62, 287. [DOI] [PubMed] [Google Scholar]
  27. Lykkesfeldt AE, Laursen I, Briand P. (1992) The role of estrogen regulated secreted proteins for growth regulation of human breast cancer cells In: Dogliotti L, Sapino A, Bussolati G, eds. Breast Cancer: Biological and Clinical Progress. Boston : Kluwer Academic Publishers, 81. [Google Scholar]
  28. Lykkesfeldt AE, Madsen MW, Briand P. (1994) Altered expression of estrogen‐regulated genes in a tamoxifen‐resistant and ICI 164, 384 and ICI 182, 780 sensitive human breast cancer cell line, MCF7/TAMR‐1. Cancer Res. 54, 1587. [PubMed] [Google Scholar]
  29. Mouridsen H, Palshof T, Patterson J, Battersby L. (1978) Tamoxifen in advanced breast cancer. Cancer Treat. Rev. 5, 131. [DOI] [PubMed] [Google Scholar]
  30. Osborne CK, Boldt DH, Clark GM, Trent JM. (1983) Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early, G1 phase. Cancer Res. 43, 3583. [PubMed] [Google Scholar]
  31. Osborne CK, Hobss K, Clark GM. (1985) Effects of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res. 45, 584. [PubMed] [Google Scholar]
  32. Osborne CK, Coronado EB, Robinson JP. (1987) Human breast cancer in the athymic nude mouse: Cytostatic effects of long‐term antiestrogen therapy. Eur. J. Cancer Clin. Oncol. 23, 1189. [DOI] [PubMed] [Google Scholar]
  33. Otto AM, Paddenberg R, Schubert S, Mannherz HG. (1996) Cell cycle arrest, micronucleus formation, and cell death of MCF‐7 breast cancer cells by amoxifen and cisplatin. J. Cancer Res. Clin. Oncol. 122, 603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Perry RR, Kang Y, Greaves B. (1995) Effects of tamoxifen on growth and apoptosis of estrogen‐dependent and ‐independent human breast cancer cells. Ann. Surg. Oncol. 2, 238. [DOI] [PubMed] [Google Scholar]
  35. Pike MC, Spicer DV, Dahmoush L, Press MF. (1993) Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol. Rev. 15, 17. [DOI] [PubMed] [Google Scholar]
  36. Reddel RR, Sutherland RL. (1984) Tamoxifen stimulation of human breast cancer cell proliferation in vitro: a possible model for tamoxifen tumour flare. Eur. J. Cancer Clin. Oncol. 20, 1419. [DOI] [PubMed] [Google Scholar]
  37. Santen RJ, Manni A, Harvey H, Redmond C. (1990) Endocrine treatment of breast cancer in women. Endocrine Rev. 11, 221–265. [DOI] [PubMed] [Google Scholar]
  38. Sutherland RL, Green MD, Hall RE, Reddel RR, Taylor IW. (1983) Tamoxifen induces accumulation of MCF human mammary carcinoma cells in the G0/G1 phase of the cell cycle. Eur. J. Cancer Clin. Oncol. 19, 615. [DOI] [PubMed] [Google Scholar]
  39. Tamir S, Kadner SS, Katz J, Finlay TH. (1990) Regulation of antitrypsin and antichymotrypsin synthesis by MCF‐7 breast cancer cell sublines. Endocrinology 127, 1319. [DOI] [PubMed] [Google Scholar]
  40. Tenniswood M, Taillefer D, Lakins J et al. (1994) Control of gene expression during apoptosis in hormone‐dependent tissues In: Tomei LD, Cope FO, eds. Apoptosis II: Molecular Basis of Apoptosis in Disease. Cold Spring Habor, NY : Cold Spring Harbor Laboratory Press, 283. [Google Scholar]
  41. VAN DER Burg B, Van Selm‐miltenburg AJP, Laat SW, Van Zoelen EJJ. (1989) Direct effects of estrogen on c‐fos and c‐myc protooncogene expression and cellular proliferation in human breast cancer cells. Mol. Cell. Endorcinol. 64, 223. [DOI] [PubMed] [Google Scholar]
  42. Wang TTY, Phang JM. (1995) Effects of estrogen on apoptotic pathways in the human breast cancer cell line MCF‐7. Cancer Res. 55, 2487. [PubMed] [Google Scholar]
  43. Watts CKW, Sweeney KJE, Warlters A, Musgrove EA, Sutherland RL. (1994) Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF‐7 human breast cancer cells. Breast Cancer Res. Treat. 31, 95. [DOI] [PubMed] [Google Scholar]
  44. Weichselbaum RR, Hellman S, Piro AJ, Nove JJ, Little JB. (1978) Proliferation kinetics of a human breast cancer line in vitro following treatment with 17β‐estradiol and 1‐β‐D‐arabino‐furanosylcytosine. Cancer Res. 38, 2339. [PubMed] [Google Scholar]
  45. Wilson JW, Wakeling AE, Morris ID, Hickman JA, Dive C. (1995) MCF‐7 human mammary adenocarcinoma cell death in response to hormone withdrawal and DNA damage. Int. J. Cancer 61, 502. [DOI] [PubMed] [Google Scholar]
  46. Wright N, Alison M. (1984) The Biology of Epithelial Cell Populations, Vol. 1. Oxford : Clarendon Press. [Google Scholar]
  47. Wärri AM, Huovinen RL, Laine AM, Martikainen PM, Häkönen PL. (1993) Apoptosis in torimifene‐induced growth inhibition of human breast cancer cells in vivo and in vitro . J. Natl. Cancer Inst. 85, 1412. [DOI] [PubMed] [Google Scholar]
  48. Zakeri Z, Bursch W, Tenniswood M, Lockshin RA. (1995) Cell death: programmed, apoptosis, necrosis, or other? Cell Death Differ. 2, 87. [PubMed] [Google Scholar]

Articles from Cell Proliferation are provided here courtesy of Wiley

RESOURCES